Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0001209191-23-002414 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-06 | 2023-01-04 | NTLA | Goddard Glenn | EVP, CFO | S - Sale | $37.21 | -2,427 | 15.4K | -14% | -$90.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | S | D | 2,427 | $37.21 | 15,404 | D | — | — |